Tetrathiomolybdate, a copper chelator, inhibits ATP7B activity in ovarian cancer models, restoring cisplatin sensitivity by blocking drug export (Ryumon et al., 2019; Fang et al., 2019). This evidence concerns the gene ATP7B and ovarian carcinoma.